Dr. De Wilde Fernand
ActiveFrom the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Dr. De Wilde Fernand has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €971,411 and a net result of €364,008. Its solvency ranks better than 40% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 18-12-2023 Normal situation
- Legal form
- Private limited company
- Registered office
- Kortrijksesteenweg 206, 9830 Sint-Martens-Latem
- Activity
- Specialist medical practice NACE 86220
- Establishment units
- 4 establishment units
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2025
Board and ownership
Board
- Eqiris NVDirector · since 04-01-2024 · permanent representative Maria Dieltiëns
- Signifeye NVDirector · since 04-01-2024 · permanent representative Kathleen Moons
- DE WILDE Fernand André MarieDirector · since 18-12-2023
Shareholders
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €1.3m
- ▼ 44.9%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €364,008
- ▼ 61.0%
- Equity
- €971,411
- ▲ 0.4%
- Total assets
- €2.0m
- ▼ 11.7%
- Staff
- 9 FTE
- ▲ 73.1%
2025 accounts filed 31 days before the deadline
Filed on 30-06-2026at the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.35, cash €409,910Figures for financial year 2025 (filed on 30-06-2026)Equity €971,411 (47.8% of total assets)Show the evidence
Checked score
Score 2025
92
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 36% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
73+6
equity 47.8% of total assets
Liquidity
49-8
short-term debt 51.3% · cash 20.2%
Profitability
91-9
return on assets 17.9%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
01-2025: 0.4%
02-2025: 0.4%● unchanged vs 01-2025
03-2025: 0.4%● unchanged vs 02-2025
04-2025: 0.4%● unchanged vs 03-2025
05-2025: 0.4%● unchanged vs 04-2025
06-2025: 0.4%● unchanged vs 05-2025
07-2025: 0.4%● unchanged vs 06-2025highest value
08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: 0.1%▲ +0.1 percentage points vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.2%▲ +0.1 percentage points vs 08-2026
10-2026: < 0.1%▼ -0.2 percentage points vs 09-2026
Credit of up to €85,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is tight, with a current ratio of 1.35 (1.3 in 2024), below the usual 1.5. Short-term debt is 51.3% and cash 20.2% of total assets. 52.2% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 38% of them on solvency, 17% on liquidity, 47% on profitability and 40% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2023, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
31 days early
2024
6 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 19 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
Key points
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 30-06-2026
- Annual accounts 2024filed on 25-07-2025
Acts in the Belgian Official Gazette
- Amendment of the articlesact of 11-02-2026
- Resignations & appointmentsact of 07-02-2024
- Incorporationact of 10-01-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Dr. De Wilde Fernand
- What is the company number of Dr. De Wilde Fernand?
- The company number of Dr. De Wilde Fernand is 1004.052.740. The VAT number is the same number with BE in front: BE 1004.052.740.
- Where is Dr. De Wilde Fernand based?
- The registered office is at Kortrijksesteenweg 206, 9830 Sint-Martens-Latem.Company details
- What does Dr. De Wilde Fernand do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. De Wilde Fernand?
- The legal form of Dr. De Wilde Fernand is Private limited company (BV).
- When was Dr. De Wilde Fernand founded?
- Dr. De Wilde Fernand was founded on 18-12-2023.
- Is Dr. De Wilde Fernand still active?
- Yes, Dr. De Wilde Fernand is an active enterprise in the KBO register.
- How many employees does Dr. De Wilde Fernand have?
- Dr. De Wilde Fernand had an average of 9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Dr. De Wilde Fernand?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €1.3m and 64 comparable companies (NACE 86). It probably lies between €1.0m and €1.7m.
- Is Dr. De Wilde Fernand profitable?
- In financial year 2025, Dr. De Wilde Fernand made a profit of €364,008.
- Where can I find the annual accounts of Dr. De Wilde Fernand?
- Dr. De Wilde Fernand filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of Dr. De Wilde Fernand due?
- Dr. De Wilde Fernand must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Companies linked to Dr. De Wilde Fernand
Comparable companies
These companies have the same main activity as Dr. De Wilde Fernand: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €2.6m, founded between 2020 and 2024.
| Company | Total assets | Gross margin |
|---|---|---|
| Dr. De Wilde Fernand Sint-Martens-Latem | €2.0m | €1.3m |
| OOGCENTRUM OOSTENDE Oostende | €1.0m | €1.0m |
| DIGESTIEF CENTRUM Gent | €2.6m | €1.7m |
| ZIEZONDER Bilzen-Hoeselt | €2.1m | €1.3m |
| DOKTERSHUIS ANTVERPIA Antwerpen | €1.4m | €0.7m |
| GYNAECOLOGEN EKEREN - BRASSCHAAT Antwerpen | €1.2m | €1.2m |
| Dr. De Ruyter – Dr. Luyckx Gent | €2.0m | €1.0m |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.Signifeye · 12 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.